Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christopher Louis Robinson, M.D.

Concepts (159)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Christopher Robinson's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Christopher Robinson has written about over time.
Vero Cells, 2 publications between 2004 and 2018, average publication date July 2011. Virus Replication, 2 publications between 2004 and 2018, average publication date July 2011. Antiviral Agents, 1 publications between 2018 and 2018, average publication date May 2018. Berberine, 1 publications between 2018 and 2018, average publication date May 2018. RNA, Viral, 1 publications between 2018 and 2018, average publication date May 2018. Sexually Transmitted Diseases, Viral, 1 publications between 2018 and 2018, average publication date May 2018. Spermatozoa, 1 publications between 2018 and 2018, average publication date May 2018. Testis, 1 publications between 2018 and 2018, average publication date May 2018. Yellow fever virus, 1 publications between 2018 and 2018, average publication date May 2018. Smoking Cessation, 1 publications between 2022 and 2022, average publication date June 2022. Cyclohexanecarboxylic Acids, 1 publications between 2023 and 2023, average publication date September 2023. Analgesics, 2 publications between 2023 and 2024, average publication date December 2023. Telemedicine, 1 publications between 2024 and 2024, average publication date January 2024.

To see the data from this visualization as text, click here.
Robinson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (159)
Explore
_
Co-Authors (21)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.